We are live on
!
Find out more
Cambridge Investment Research Advisors Portfolio holdings
AUM
$44.6B
1-Year Est. Return
28.94%
This Fund
S&P 500
This Quarter
Est. Return
-0.75%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$20.3B
AUM Growth
-$658M
(-3.1%)
Cap. Flow
-$389M
Cap. Flow
% of AUM
-1.92%
Top 10 Holdings %
Top 10 Hldgs %
19.94%
Holding
3,276
New
193
Increased
1,504
Reduced
1,271
Closed
193
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P US Growth ETF
IUSG
|
+$42.5M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$32.9M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$30.3M |
| 4 |
Vanguard S&P 500 ETF
VOO
|
+$25.5M |
| 5 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$21.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares S&P 500 Growth ETF
IVW
|
+$90.8M |
| 2 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$78.2M |
| 3 |
iShares S&P 500 Value ETF
IVE
|
+$51.9M |
| 4 |
Vanguard Extended Market ETF
VXF
|
+$49.6M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$46.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.58% |
| 2 | Consumer Discretionary | 4.97% |
| 3 | Financials | 4.87% |
| 4 | Healthcare | 3.87% |
| 5 | Communication Services | 3.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
526
AstraZeneca
AZN
$244B
| $6.09M | 0.03% |
50,671
+10,940
| +28% | +$1.27M |
|
527
Fidelity MSCI Materials Index ETF
FMAT
$610M
| $6.07M | 0.03% |
137,209
+60,213
| +78% | +$2.8M |
|
528
Jacobs Solutions
J
$16.8B
| $6.07M | 0.03% |
55,402
-801
| -1% | -$88.6K |
|
529
iShares Cybersecurity and Tech ETF
IHAK
$1.15B
| $6.06M | 0.03% |
139,541
+8,726
| +7% | +$387K |
|
530
Devon Energy
DVN
$48.8B
| $6.06M | 0.03% |
170,694
-239,893
| -58% | -$6.8M |
|
531
iShares US Healthcare ETF
IYH
$3.77B
| $6.05M | 0.03% |
109,725
+10,755
| +11% | +$615K |
|
532
ARK Autonomous Technology & Robotics ETF
ARKQ
$2.09B
| $6.04M | 0.03% |
77,448
-11,885
| -13% | -$971K |
|
533
Weyerhaeuser
WY
$17.9B
| $6.02M | 0.03% |
169,367
+15,852
| +10% | +$555K |
|
534
First Trust Nasdaq-100 Select Equal Weight ETF
QQEW
$1.88B
| $6M | 0.03% |
53,942
+3,681
| +7% | +$420K |
|
535
DuPont de Nemours
DD
$19.5B
| $5.99M | 0.03% |
70,149
+4,247
| +6% | +$394K |
|
536
Agilent Technologies
A
$42.2B
| $5.99M | 0.03% |
37,999
-613
| -2% | -$99.2K |
|
537
Goldman Sachs ActiveBeta Emerging Markets Equity ETF
GEM
$1.74B
| $5.95M | 0.03% |
160,434
+6,991
| +5% | +$272K |
|
538
iShares 10+ Year Investment Grade Corporate Bond ETF
IGLB
$2.8B
| $5.93M | 0.03% |
85,581
-53,136
| -38% | -$3.77M |
|
539
Cable One
CABO
$206M
| $5.92M | 0.03% |
3,267
-333
| -9% | -$652K |
|
540
Marathon Petroleum
MPC
$100B
| $5.92M | 0.03% |
95,783
+1,982
| +2% | +$114K |
|
|
SLY
541
DELISTED
SPDR S&P 600 Small Cap ETF (based on S&P SmallCap 600 Index--symbol SML)
SLY
| $5.88M | 0.03% |
62,016
-8,573
| -12% | -$817K |
|
542
Chubb
CB
$133B
| $5.87M | 0.03% |
33,823
-791
| -2% | -$139K |
|
543
Schwab Fundamental International Large Company Index ETF
FNDF
$25.8B
| $5.86M | 0.03% |
178,455
-131,025
| -42% | -$4.34M |
|
544
Invesco Dorsey Wright Healthcare Momentum ETF
PTH
$243M
| $5.84M | 0.03% |
108,843
-3,198
| -3% | -$179K |
|
|
ZOM
545
DELISTED
Zomedica Corp.
ZOM
| $5.83M | 0.03% |
11,141,815
-1,473
| -0% | -$869 |
|
546
Tyson Foods
TSN
$19.8B
| $5.82M | 0.03% |
73,744
+9,387
| +15% | +$709K |
|
547
IQVIA
IQV
$39.8B
| $5.81M | 0.03% |
24,259
-7,671
| -24% | -$1.94M |
|
548
WEC Energy
WEC
$35.9B
| $5.8M | 0.03% |
65,791
-2,786
| -4% | -$261K |
|
549
Global X Lithium & Battery Tech ETF
LIT
$1.6B
| $5.79M | 0.03% |
70,687
+25,322
| +56% | +$2.08M |
|
550
Cohen & Steers Quality Income Realty Fund
RQI
$1.69B
| $5.76M | 0.03% |
386,753
+62,004
| +19% | +$990K |
|
Similar funds
LP
HF
Cambridge Investment Research Advisors's Q3 2021 Portfolio in Review
As of Q3 2021, Cambridge Investment Research Advisors held 3,276 positions worth $20.3B, down 3.1% from $20.9B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Cambridge Investment Research Advisors's Q3 2021 filing shows 193 new, 1,504 increased, 1,271 reduced and 193 closed positions. Its largest new stake was Dimensional World ex US Core Equity 2 ETF: 269,623 shares worth $6.98M. The largest sale was iShares S&P 500 Growth ETF, an estimated $90.8M.
By sector, the portfolio is most concentrated in Technology at 9.6% of assets, up from 9.3% a quarter earlier, followed by Consumer Discretionary and Financials.
- Cambridge Investment Research Advisors's largest Q3 2021 buy was Dimensional World ex US Core Equity 2 ETF: 269,623 shares worth $6.98M.
- Cambridge Investment Research Advisors added most to iShares Core S&P US Growth ETF in Q3 2021, an estimated $42.5M increase.
- Cambridge Investment Research Advisors's biggest Q3 2021 reduction was iShares S&P 500 Growth ETF, cutting an estimated $90.8M.
- Cambridge Investment Research Advisors fully exited VanEck Steel ETF in Q3 2021, selling an estimated $6.22M.
- Cambridge Investment Research Advisors's ten largest holdings make up 20% of its $20.3B portfolio in Q3 2021.
- Cambridge Investment Research Advisors opened 193 new positions and closed 193 in Q3 2021.
- Cambridge Investment Research Advisors's portfolio value fell 3.1% quarter-over-quarter to $20.3B.
Based on Cambridge Investment Research Advisors's 13F filing for Q3 2021, filed 2 Nov 2021.